Evidence map›Paper›PMID 29680966›Full record

ArticlePsychopharmacology2018

Mnemonic and behavioral effects of biperiden, an M1-selective antagonist, in the rat.

Anna Popelíková, Štěpán Bahník, Veronika Lobellová, Jan Svoboda, Aleš Stuchlík

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Anna PopelíkováInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic.
Štěpán BahníkThe Prague College of Psychosocial Studies, Hekrova 805, 149 00, Prague, Czech Republic.
Veronika LobellováInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic.
Jan SvobodaInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic. svobodaj@biomed.cas.cz.ORCID http://orcid.org/0000-0002-0343-5347
Aleš StuchlíkInstitute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic. ales.stuchlik@fgu.cas.cz.
Czech Academy of Sciences · CZPrague College of Psychosocial Studies · CZ

Funding

Akademie Věd České Republiky RVO: 67985823Grantová Agentura České Republiky 17-04047S
6 · The paper itself

Abstract

rationaleThere is a persistent pressing need for valid animal models of cognitive and mnemonic disruptions (such as seen in Alzheimer's disease and other dementias) usable for preclinical research.

objectivesWe have set out to test the validity of administration of biperiden, an M1-acetylcholine receptor antagonist with central selectivity, as a potential tool for generating a fast screening model of cognitive impairment, in outbred Wistar rats.

methodsWe used several variants of the Morris water maze task: (1) reversal learning, to assess cognitive flexibility, with probe trials testing memory retention; (2) delayed matching to position (DMP), to evaluate working memory; and (3) "counter-balanced acquisition," to test for possible anomalies in acquisition learning. We also included a visible platform paradigm to reveal possible sensorimotor and motivational deficits.

resultsA significant effect of biperiden on memory acquisition and retention was found in the counter-balanced acquisition and probe trials of the counter-balanced acquisition and reversal tasks. Strikingly, a less pronounced deficit was observed in the DMP. No effects were revealed in the reversal learning task.

conclusionsBased on our results, we do not recommend biperiden as a reliable tool for modeling cognitive impairment.

Indexed as

Disease Models, AnimalRatsAlzheimer DiseaseAnimalsBehavior, AnimalBiperidenCognitive DysfunctionMaleMaze LearningMemory DisordersMemory, Short-TermMuscarinic AntagonistsRats, WistarReversal LearningBiperidenMuscarinic AntagonistsAnticholinergicsLearningMemoryMorris water mazeMuscarinic receptorsRat

Identifiers

PMID29680966
OpenAlexW2799594972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.